What prior treatment requirement applies to cemiplimab (Libtayo) for adults with locally advanced or metastatic basal cell carcinoma?

Cemiplimab (Libtayo) is indicated as monotherapy for adults with locally advanced or metastatic basal cell carcinoma who have progressed on or are intolerant to a hedgehog pathway inhibitor.